Skip to navigation Skip to content

Gastrointestinal stromal tumour Program in Pharmaceutical Benefits Scheme (PBS) 012-18053000

Expand/Collapse all sectionsExpand all


Gastrointestinal stromal tumour (GIST) restriction and item codes

Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.

\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.pngPBS GIST restriction and item codes

Contact details

PBS Complex Drugs Programs team

Forms

Gastrointestinal stromal tumour - sunitinib - initial authority application form (PB096)

Services Australia website

Gastrointestinal stromal tumour

External websites

PBS schedule for gastrointestinal stromal tumour (GIST)

FAQs from Service Officers

Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.

Item

Description

1

How many months of imatinib treatment is available on the PBS for patients with adjuvant GIST?

The PBS allows for a total of 36 months of treatment (initial plus continuing therapy). As continuing treatment is a streamlined PBS authority, the onus is on the prescriber not to exceed this 36-month limit.

2

Is there an age restriction for any medication on this program?

No, providing all PBS criteria has been met, a patient of any age can be approved.